For the Quarter Ending June 2026
Rifaximin Prices in North America
- In the USA, the Rifaximin Price Index rose by 10.1036% quarter-over-quarter, reflecting freight-driven landed cost increases.
- The average Rifaximin price for the quarter was approximately USD 137053.33/MT CFR Los Angeles assessments.
- Rifaximin Spot Price remained supported by prescriptions while freight inflation kept spot leverage with sellers.
- Rifaximin Price Forecast indicates near-term pullbacks then recovery as importers rebalance inventories and orders promptly.
- Rifaximin Production Cost Trend rose due to higher solvent and energy costs at origin plants.
- Rifaximin Demand Outlook stays firm, driven by prescription growth and limited generic competition during litigation.
- Inventory cover remained six weeks, so Rifaximin Price Index reacted to logistics rather than outages.
- Export supply from Italy and India remained normal while port and war-driven changes tightened availability.
Why did the price of Rifaximin change in June 2026 in North America?
- Trans-Pacific container freight surged, raising landed costs and enabling exporters to pass through higher offers.
- Origin ex-plant supply remained uninterrupted, so demand-supply balance allowed logistics-driven increases rather than quantity-driven shortages.
- Steady branded prescription growth maintained downstream pull, limiting buyer resistance to accepting freight-driven price increases.
Rifaximin Prices in APAC
- In China, the Rifaximin Price Index rose by 10.06% quarter-over-quarter, reflecting firmer feedstock and export demand.
- The average Rifaximin price for the quarter was approximately USD 136880.00/MT, based on FOB shipments.
- Rifaximin Spot Price tightened as May inspections reduced output, permitting Chinese sellers to firm offers.
- Rifaximin Price Forecast indicates modest June gains, followed by mid-summer correction, reflecting seasonal demand normalization.
- Rifaximin Production Cost Trend shows upward pressure from rifamycin SV import prices and higher energy costs.
- Rifaximin Demand Outlook remains constructive offshore with India and Brazil restocking, offsetting domestic prescription growth.
- Rifaximin Price Index supported by balanced inventories; maintenance outages tightened spot availability, keeping seller discipline.
- Export demand and higher freight insurance elevated landed costs, keeping offers supported, margins under pressure.
Why did the price of Rifaximin change in June 2026 in APAC?
- Tightened supply from short maintenance and provincial inspections reduced exportable volumes, supporting modest FOB price increases.
- Rising rifamycin SV import prices and elevated freight insurance raised landed feedstock and logistics costs.
- Sustained offshore demand from India and Brazil absorbed incremental supply, allowing exporters to defend higher offers.
India
- In India, the Rifaximin Price Index rose by 5.96% quarter-over-quarter, supported by stronger export enquiries.
- Rifaximin Spot Price firmed as replacement intermediate purchases and tighter merchantable stocks raised prompt availability.
Rifaximin Prices in Europe
- In Germany, the Rifaximin Price Index rose by 10.08% quarter-over-quarter, driven by higher landed costs.
- The average Rifaximin price for the quarter was approximately USD 137023.33/MT, including CFR Hamburg shipments
- Rifaximin Spot Price firmed as container surcharges and cold-chain constraints elevated landed costs into Europe.
- Rifaximin Price Forecast indicates moderate increases in June, slight correction expected mid-summer as inventories normalize.
- Rifaximin Production Cost Trend reflects higher fermentation utility tariffs and compliance charges raising FOB offers.
- Rifaximin Demand Outlook remains firm with mid-single-digit prescription growth supporting merchant procurement ahead of holidays.
- Rifaximin Price Index gains were partially absorbed by statutory price caps, compressing wholesaler margins in Germany
- Italian and Indian producers operated near capacity with planned maintenance tightening availability, supporting firmer offers
Why did the price of Rifaximin change in June 2026 in Europe?
- Elevated freight and war-risk insurance increased landed costs, constraining margins and supporting higher import offers.
- Higher fermentation utility tariffs and environmental compliance charges in Asia pushed up FOB quotations in Europe
- Cold-chain capacity tightness and container surcharges reduced stocks, prompting buyers to accept firmer landed pricing.
For the Quarter Ending March 2026
Rifaximin Prices in APAC
- In China, the Rifaximin Price Index rose by 2.64% quarter-over-quarter due to tighter output and exports.
- The average Rifaximin price for the quarter was approximately USD 124366.67/MT, reflecting mixed hospital demand.
- Tighter availability reduced Rifaximin Spot Price volatility, prompting selective restocking among regional formulators and traders.
- Rifaximin Production Cost Trend showed upward pressure from higher rifamycin SV import costs and steam expenses.
- Rifaximin Demand Outlook strengthened offshore as India and Brazil increased tenders, supporting firmer export negotiations.
- Inventory drawdowns left the Rifaximin Price Index more responsive to booking flows and short-term supplier discipline.
- Rifaximin Price Forecast points to limited near-term upside given balanced supply, though geopolitical risks remain.
- Operational audits and environmental inspections intermittently disrupted output, tightening spot availability and supporting short-term bullish sentiment.
Why did the price of Rifaximin change in March 2026 in APAC?
- Domestic production curbs from environmental audits reduced output, shrinking inventories and lifting sellers' negotiating leverage.
- Rifamycin SV import delays, higher steam energy expenses raised conversion costs, pressuring margins and offers.
- Export bookings from India and Brazil tightened spot availability, accelerating forward purchases and supporting rallies.
Rifaximin Prices in Europe
- In Germany, the Rifaximin Price Index rose by 2.66% quarter-over-quarter, reflecting tighter import availability recently
- The average Rifaximin price for the quarter was approximately USD 124473.33/MT, supporting measured replenishment activity.
- Rifaximin Spot Price firmed as container shortages and higher cold-chain handling pushed landed costs for lots.
- Rifaximin Price Forecast shows tightness driven by constrained fermentation capacity and selective restocking by distributors.
- Rifaximin Production Cost Trend elevated due to wastewater treatment compliance costs and increased fermentation expenses.
- Rifaximin Demand Outlook remains supportive from prescription volumes and seasonal traveler prophylaxis ahead of Easter
- Rifaximin Price Index reflected stronger offers as import quotas tightened and buyers prioritized assured supply
- Inventories remained stable, limiting upside, while exporters offered disciplined nominations, sustaining narrow range-bound trading conditions
Why did the price of Rifaximin change in March 2026 in Europe?
- Tighter export allocations from India, Italy, and China reduced shipments, constraining supply into German ports.
- Higher cold-chain handling premiums, customs clearance delays, and freight rates increased landed costs in March
- Sustained mid-single-digit prescription demand and pre-Easter restocking kept buyers active, supporting upward price momentum firmly
Rifaximin Prices in North America
- In the USA, the Rifaximin Price Index rose by 2.64% quarter-over-quarter, driven by stronger prescriptions and restocking.
- The average Rifaximin price for the quarter was approximately USD 124476.67/MT, reflecting balanced fundamentals overall.
- Rifaximin Spot Price liquidity remained limited in Los Angeles, constraining aggressive buying and bid-ask spreads.
- Rifaximin Price Forecast indicates modest volatility as freight and prescription trends drive short-term directional movement.
- Rifaximin Production Cost Trend rose because container freight and insurance premiums increased the landed cost components.
- Rifaximin Demand Outlook remains constructive with mid-single-digit prescription growth and measured wholesaler restocking activity ongoing.
- Inventory draws left distributor coverage under four weeks, increasing Rifaximin Price Index sensitivity to delays.
- Suppliers maintained disciplined offers with selective forward sales, keeping transaction volumes controlled while limiting corrections.
Why did the price of Rifaximin change in March 2026 in North America?
- Sharp Shanghai to Los Angeles freight increases raised landed costs, translating into higher CFR offers.
- Distributor inventories under four weeks forced prompt restocking, supporting sellers' stronger pricing discipline despite production.
- Sustained prescription growth and preparatory buying ahead of second-quarter seasonality increased demand pressure for wholesalers.
For the Quarter Ending December 2025
North America
- In the USA, the Rifaximin Price Index rose by 5.86% quarter-over-quarter, reflecting higher landed costs from China.
- The average Rifaximin price for the quarter was approximately USD 279185.00/MT per CFR Los Angeles.
- Rifaximin Spot Price firmed on controlled exports and steady shipments into West Coast distribution networks.
- Rifaximin Price Forecast indicates gradual modest increases as buyers advance orders ahead of reimbursement adjustments.
- Rifaximin Production Cost Trend showed stability overall, with localized cost pressure from Chinese manufacturing disruptions.
- Rifaximin Demand Outlook remained resilient owing to steady prescriptions and brand-driven offtake supporting firm offers.
- Rifaximin Price Index benefited from supplier offers and limited spot discounting despite softer freight costs.
- Inventory and export demand balanced availability, while port operations normalized, sustaining narrow upward price momentum.
Why did the price of Rifaximin change in December 2025 in North America?
- Buyers' advanced orders anticipating reimbursement changes, allowing exporters to pass a modest premium onto CFR invoices.
- Stable supply from Italy and India, declining freight rates, yet sellers maintained firm contract offers.
- Consistent prescription demand and brand exclusivity reduced discounting, supporting price firmness despite flat production economics.
APAC
- In China, the Rifaximin Price Index rose by 5.87% quarter-over-quarter, driven by export strength globally.
- The average Rifaximin price for the quarter was approximately USD 279100.00/MT, supporting measured seller discipline.
- Rifaximin Spot Price firmed modestly as Shanghai free-trade warehouses kept moderate stocks and steady shipments.
- Rifaximin Production Cost Trend rose as rifamycin SV import costs and euro strength pressured converters.
- Rifaximin Demand Outlook stayed constructive as hospital tenders and international buyers maintained disciplined restocking schedules.
- Rifaximin Price Forecast suggests a mild upward trajectory as exporters hold firm offers amid steady offtake.
- Rifaximin Price Index movements were muted by balanced inventories and normalized reefer freight on lanes.
- Zhejiang and Jiangsu plants operated near capacity, preserving export volumes while avoiding environmental compliance-related shutdowns.
Why did the price of Rifaximin change in December 2025 in APAC?
- Export call-offs from India and Brazil increased in December, tightening availability despite steady domestic output.
- Firmer rifamycin SV feedstock and stronger euro raised conversion costs, leading producers lift FOB offers.
- Shanghai port normalization and steady reefer freight avoided bottlenecks, allowing increased loading and timely shipments.
Europe
- In Germany, the Rifaximin Price Index rose by 5.85% quarter-over-quarter, driven by Chinese production costs.
- The average Rifaximin price for the quarter was approximately USD 279173.33/MT, reflecting Hamburg landed costs.
- Rifaximin Spot Price liquidity was thin, while the Price Index firmed on imports and restocking.
- Rifaximin Price Forecast shows gains as Rifaximin Production Cost Trend sustains upward pressure from intermediates.
- Rifaximin Demand Outlook remains positive, supporting the Price Index as prescriptions and distributor offtake grow.
- Rifaximin Price Index sensitivity to currency and logistics compelled importers to absorb costs, constraining pass-through.
- Major origins Italy, India, and China operated normally, exporters adjusted offers reflecting marginally tighter inventories.
- Forward buying supported moderate gains; Rifaximin Price Forecast and Spot Price outlook suggest gradual firming.
Why did the price of Rifaximin change in December 2025 in Europe?
- Elevated Asian production costs increased FOB levels, transmitting higher landed costs into Germany's import market.
- Logistics friction and handling premiums at Hamburg lengthened lead times and increased CFR landed-price components.
- Solid prescription demand and distributor restocking, constrained by rebate rules, supported steady offtake without pass-through.
For the Quarter Ending September 2025
North America
- In USA, the Rifaximin Price Index rose by 0.08% quarter-over-quarter, reflecting marginal forward buying activity.
- The average Rifaximin price for the quarter was approximately USD 263728.33/MT, based on invoiced imports.
- Rifaximin Spot Price remained subdued with stable supply, keeping the Rifaximin Price Index largely flat.
- Rifaximin Price Forecast indicates upward bias as Rifaximin Production Cost Trend sees persistent inflationary pressure.
- Rifaximin Demand Outlook points to steady healthcare offtake supporting the Price Index through seasonal cycles.
- Inventory buffers drawn earlier limited urgent imports, reducing pressure on the Rifaximin Price Index short-term.
- Major supplier operational continuity maintained, while freight volatility influenced Rifaximin Production Cost Trend and costs.
- Market participants adopt cautious buying; Rifaximin Price Forecast expects controlled rises amid measured replenishment activity.
Why did the price of Rifaximin change in September 2025 in North America?
- Precautionary forward buying amid tariff uncertainty temporarily increased inbound demand, nudging prices slightly upward recently.
- Elevated inventories from earlier strategic imports reduced replenishment urgency, placing downward pressure on spot Price Index.
- Logistics stability with minor port delays increased landed costs modestly, influencing near-term Price Index movement.
APAC
- In China, the Rifaximin Price Index rose by 0.10% quarter-over-quarter, supported by stable export interest.
- The average Rifaximin price for the quarter was approximately USD 263633.33/MT, reflecting balanced market conditions.
- Producers reported manageable inventories and balanced shipments, keeping the Rifaximin Spot Price stable through September.
- Outlook indicates modest upside as the Rifaximin Price Forecast factors steady demand and holiday logistics.
- Freight and raw material shifts altered the Rifaximin Production Cost Trend, applying upward pressure overall.
- Global procurement pauses and domestic restocking shaped the Rifaximin Demand Outlook, leaving volumes steady, cautious.
- Export variability and occasional sailing cancellations affected distribution and reflected in the Rifaximin Price Index.
- Manufacturers sustained production alignment with orders, avoiding overstocking while maintaining offers and margin stability overall.
Why did the price of Rifaximin change in September 2025 in APAC?
- Mild export restocking and steady domestic procurement increased demand slightly, supporting marginal net price gains.
- Container freight cost increases added logistical expense, prompting suppliers to pass through limited cost recoveries.
- Domestic manufacturing stability prevented oversupply despite softer external orders, balancing market and preventing larger declines.
Europe
- In Germany, the Rifaximin Price Index rose by 0.10% quarter-over-quarter, in Q3 2025, reflecting logistical stability and procurement restraint.
- The average Rifaximin price for the quarter was approximately USD 263740.00/MT, based on reported CFR Hamburg shipments.
- Rifaximin Spot Price remained muted, and the Rifaximin Price Index showed minimal upward pressure amid cautious buying.
- Rifaximin Price Forecast indicates marginal gains through Q4 as logistics normalize and selective forward buying supports modest firmness.
- Rifaximin Production Cost Trend remained steady with limited feedstock or manufacturing cost escalation influencing list prices modestly.
- Rifaximin Demand Outlook stays stable; hospitals and pharmacies maintain short-cycle orders, avoiding speculative bulk procurement.
- Inventory buffers across German warehouses dampened volatility while export demand remained limited, keeping spot offers subdued.
- Major producer maintenance and selective Chinese offloads influenced offers, while port congestion adjustments limited shipment frequency.
Why did the price of Rifaximin change in September 2025 in Europe?
- Moderate port congestion delayed shipments slightly, creating mild supply timing issues without substantial shortages overall.
- Freight schedule variability and carrier re-routing increased logistical costs, prompting cautious procurement and timing adjustments.
- Adequate inventories and restrained forward buying prevented sharp price moves despite shipping and geopolitical risks.
